Exactech Revolutionizes Ankle Implants with Activit-E™ Polyethylene: Enhancing the Vantage® Total Ankle System”
Exactech, a trailblazer in innovative joint replacement solutions, has received FDA 510(k) clearance for Activit-E™ polyethylene, a groundbreaking addition to the Vantage® Total Ankle System. This milestone follows closely on the heels of the Activit-E clearance for the Truliant® Knee System, unveiled just last month.
Engineered for the demands of an active patient population, Activit-E represents a leap forward in highly crosslinked polyethylene, fortified with vitamin E antioxidant stabilization. This advanced material exhibits superior wear resistance and greater fracture toughness compared to other highly crosslinked vitamin E polyethylenes, making it an ideal choice for implant design.
Activit-E’s cutting-edge manufacturing process eschews traditional gamma irradiation crosslinking in favor of peroxide crosslinking, fortified with vitamin E to deliver unmatched strength, flexibility, toughness, and oxidative stability. Notably, this innovative approach ensures patients continue to benefit from highly crosslinked polyethylene, even amidst anticipated shortages of gamma radiation for crosslinking.
Exactech’s Director of Engineering, Foot and Ankle, Matt Hamilton, expressed excitement about this development. He stated, “We’re excited to bring Activit-E to the ankle portfolio. This advanced material gives us the best-wear performance we’ve tested combined with higher fracture toughness than other highly crosslinked vitamin E polyethylenes. Both are important factors when designing implants for a very active patient population.”
Activit-E was developed by the pioneering team led by Dr. Orhun Muratoglu, Director of the Harris Orthopaedic Laboratory at Massachusetts General Hospital in Boston, and Dr. Ebru Oral, Director of Biomaterials Research. The team’s groundbreaking work includes inventing the first-generation highly crosslinked polyethylene and pioneering vitamin E stabilization in highly crosslinked polyethylenes now in global clinical use.
The pilot launch for Activit-E is slated for the first quarter of 2024. Attendees at this week’s American Orthopaedic Foot and Ankle Society (AOFAS) Annual Meeting can get an exclusive first look at this groundbreaking technology at Exactech’s booth (#301).
In the realm of orthopaedic innovation, Exactech stands as a global trailblazer. This dynamic medical device company, headquartered in the vibrant city of Gainesville, Florida, is at the forefront of developing and marketing cutting-edge orthopaedic implant devices and surgical instruments. However, their innovation doesn’t stop there. Exactech also offers the Active Intelligence® platform, a collection of smart technologies that empower hospitals and physicians to deliver exceptional patient care.
With a reach that spans across the United States and extends to over 30 markets throughout Europe, Latin America, Asia, and the Pacific, Exactech is committed to enhancing the lives of patients worldwide through their revolutionary orthopaedic solutions. Their dedication to advancing healthcare knows no bounds, as they continue to shape the future of orthopaedics with their innovative products and technologies.